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A recombinant mesogenic NDV strain, Beaudette C, and an engineered recombinant NDV expressing an additional gene
were generated entirely from cloned cDNAs. For this purpose, a full-length cDNA clone of the virus genome, represented in
eight different subgenomic fragments, was assembled in a transcription plasmid between a T7 RNA polymerase promoter
and a hepatitis delta virus ribozyme sequence. Infectious NDV could be generated in the cells infected with recombinant
vaccinia virus, which expressed T7 RNA polymerase, by simultaneous expression of antigenome-sense NDV RNA from the
full-length plasmid and NDV NP, P, and L proteins from cotransfected plasmids. Recombinant virus was then amplified and
recovered, either after inoculation of transfection supernatant into the allantoic cavity of embryonated specific-pathogen-free
eggs or after further passage in cell culture. Characterization of the recombinant NDV showed similarities in growth and
pathogenicity to that of the parental wild-type virus. By using this system, a recombinant NDV containing a foreign gene
encoding chloramphenicol acetyltransferase (CAT) was generated. To do this, the CAT transcription cassette containing the
CAT open reading frame, flanked by NDV gene start and gene end sequence motifs, was inserted into the region between
the HN and L genes of the full-length cDNA. This construct was then used in the generation of a recombinant NDV expressing
CAT protein. The CAT gene was maintained stably for at least eight passages without any detectable loss of the gene from
the recombinant. Generation of the recombinant virus, however, was associated with reduced plaque size, slower replication
kinetics, and more than 100-fold decrease in yield. In addition, the virus showed an increase in mean death time for eggs and
a lower intracerebral pathogenicity index in day-old chicks, implicating attenuation of the recombinant virus. Thus, introduc-
tion of an additional gene into the NDV genome represents a method to achieve growth retardation and attenuation. These
results also indicate that NDV can be engineered to express foreign protein stably and can be manipulated in the future for
use as a vaccine vector. © 2000 Academic PressINTRODUCTION
Newcastle disease is a highly contagious and eco-
nomically most important disease of poultry. The disease
also inflicts many other avian species. The disease var-
ies in degree of severity, ranging from mild, inapparent
infection to severe disease, causing 100% mortality (Al-
exander, 1997). Based on the severity of the disease in
chickens, the causative agent of the disease, Newcastle
disease virus (NDV), is divided into three pathotypes: (1)
the lentogenic strains, which cause mild inapparent in-
fection; (2) the mesogenic strains, which cause mild
respiratory symptoms with low mortality; and (3) the
velogenic strains, which are highly virulent and cause
high mortality. Vaccination has been the widely used
method of prevention of this disease. Though vaccination
with live lentogenic NDV strains has largely controlled
the disease, a better, stable, and completely apathogenic
vaccine is desirable to ensure complete efficacy and
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168safety. Apart from the importance of producing a better
vaccine, NDV serves as an excellent model for studying
viral pathogenesis because the virulence of NDV can be
measured on a quantitative basis in chick embryos and
young chickens. Therefore, it is important to design
methods for genetically modifying NDV and to use the
engineered virus for purposes of studying pathogenesis
and constructing a better vaccine virus.
NDV is a member of the genus Rubulavirus of the
family Paramyxoviridae (Murphy et al., 1995) and con-
tains nonsegmented single-stranded negative-sense
RNA as the genome. The genome of NDV is 15,186
nucleotides long (de Leeuw and Peeters, 1999; Krish-
namurthy and Samal, 1998; Phillips et al., 1998) and
contains six genes, which encode nucleocapsid protein
(NP), phosphoprotein (P), matrix protein (M), fusion pro-
tein (F), hemagglutinin protein (HN), large protein (L), and
finally, V and W proteins, which are produced by RNA
editing during P gene transcription (Millar and Emmer-
son, 1988; Stewad et al., 1993). One aspect of NDV and
other negative-strand RNA viruses is that naked RNA
alone is not infectious. Other components of the ribonu-
cleoprotein complex (RNP), namely NP, P, and L proteins,
are essential to initiate the first round of RNA synthesis
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169RECOVERY OF VIRULENT STRAIN OF NDV FROM CLONED cDNAand establish infection. So the current technique of ge-
netic manipulation of negative-strand RNA viruses by
reverse genetics involves cotransfection, into permissive
cells, of plasmids expressing full-length RNA and NP, P,
and L proteins, all under the control of T7 promoter. This
results in reconstitution of the RNP complex inside the
cell and recovery of the virus. The source of the T7 RNA
polymerase is either a recombinant vaccinia virus ex-
pressing the gene or a cell line constitutively expressing
the polymerase. Using this approach of recovery, rabies
virus was the first nonsegmented negative-stranded RNA
virus to be recovered entirely from cDNA (Schnell et al.,
1994). Since then, other members of nonsegmented neg-
ative-strand RNA viruses have been recovered from
cDNA: Sendai virus (Garcin et al., 1995; Kato et al., 1996),
human respiratory syncytial virus (RSV) (Collins et al.,
1995), vesicular stomatitis virus (VSV) (Lawson et al.,
1995; Whelan et al., 1995), SV5 (He et al., 1997), measles
irus (Radecke et al., 1995), parainfluenza virus 3 (Durbin
t al., 1997a; Hoffman and Banerjee, 1997), rinderpest
irus (Baron and Barrett, 1997), bovine respiratory syncy-
ial virus (Buchholz et al., 1999), and, recently, lentogenic
NDV strain La Sota (Oberdorfer et al., 1999; Peeters et al.,
1999) and mumps virus (Clarke et al., 2000).
In this report, we describe the recovery of a meso-
genic strain of NDV (Beaudette C) entirely from cDNA.
Mesogenic strains like Beaudette C are ideal for study-
ing pathogenesis because their intermediate virulence
creates a possibility to attenuate or increase their viru-
lence further by reverse genetics. In this study, the re-
covered virus was found to be biologically and antigeni-
cally similar to the parental wild-type virus. Thus, recov-
ery of a mesogenic strain of NDV would provide a means
of studying the molecular biology and pathogenesis of
NDV.
Additionally, we report here the recovery of infectious
recombinant NDV encoding a foreign protein, chloram-
phenicol acetyltransferase (CAT). The CAT coding se-
quence, flanked by NDV gene start and gene end se-
quence motifs, was inserted between the HN and L
genes of the full-length NDV cDNA. We observed in the
recovered virus a delayed growth, a decreased yield, and
a decreased virulence to embryonated chicken eggs and
day-old chicks. In addition, expression of the CAT protein
by the recombinant NDV was found to be highly stable.
These results suggested the ability to insert foreign
genes into the genome of NDV for coexpression and to
use NDV as an attenuated vaccine vector.
RESULTS
Construction of cDNA to NDV genome
Construction of the NDV cDNA clone encoding the
complete 15,186-nucleotide (nt) NDV genome of strain
Beaudette C was made possible by generating eight
individual cDNA fragments that were cloned sequentially
l
tinto the low-copy-number plasmid pBR322/dr (Fig. 1 and
Table 1). Cloning of these fragments positioned the NDV
cDNA between the T7 promoter and the hepatitis delta
virus (HDV) ribozyme sequence. The resulting NDV
cDNA in the plasmid pNDVf1 was a faithful copy of the
NDV genome, except for the following nucleotide
changes from the published sequence (Chambers et al.,
1986a,b): T5464C, A7915G, C10167T, A10877C, and
C12239T. Three of these nucleotide differences resulted
in amino acid (aa) changes: nt 7915 in the HN gene,
resulting in change of amino acid threonine to alanine
(aa position 502); nt 10167 in the L gene, resulting in
hange of amino acid threonine to methionine (aa posi-
ion 596); and nt 10877 in the L gene, resulting in change
f amino acid methionine to leucine (aa position 833).
hese changes were present in all the viral genomic
NAs that were isolated from three different stocks of
DV strain Beaudette C and subjected to reverse tran-
cription coupled PCR (RT-PCR) and sequencing. Also,
wo genetic tags were introduced in the cDNA to posi-
ively identify the recombinant virus: nt positions 6294
nd 6295 at the F/HN intergenic region were replaced
CG to GC) to create an MluI restriction site, and nucle-
tide positions 8357, 8358, and 8359 at the HN/L inter-
enic region were replaced (CAT to ACC) to create an
geI site. The biologically derived parental strain Beau-
ette C and NDV cDNA contained a double frameshift
nts 12239 and 12327) in the L gene, resulting in differ-
nces of 28 amino acids (aa 1287–1316 of the L protein)
rom the published sequence of NDV strain Beaudette C
Yusoff et al., 1987). This change, however, is in accor-
ance with the published sequence of NDV strain La
ota Clone-30 (Oberdorfer et al., 1999). To facilitate tran-
cription of T7 RNA polymerases, 3G residues were
ncluded before the NDV leader sequence. An antig-
nome (1)-sense RNA transcript was produced by tran-
cription of NDV cDNA.
ecovery of infectious recombinant NDV from cDNA
A recombinant vaccinia virus-based transfection sys-
em was used to recover infectious recombinant NDV
rom cDNA. HEp-2 cells were infected with recombinant
accinia virus (MVA/T7) capable of synthesizing T7 RNA
olymerase. Simultaneously, the cells were transfected
ith the plasmid pNDVf1, along with plasmids encoding
roteins of RNP complex, namely NP (pNP), P (pP), and
(pL). In a parallel transfection, plasmid pL was ex-
luded in the experiment to serve as a negative control.
our days after transfection, the supernatant was used in
ither of two different ways to recover the virus. The
upernatant was either injected into the allantoic cavities
f 9-day-old embryonated eggs or amplified further in
Ep-2 cells and DF1 cells (chicken embryo fibroblast celline). The allantoic fluid of the eggs injected with the
ransfectant gave a positive hemagglutination (HA) titer
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170 KRISHNAMURTHY, HUANG, AND SAMALranging from 32 to 2048. The cell culture-amplified su-
pernatant gave NDV titers slightly in excess of 104
plaque-forming units (PFU)/ml at the end of passage 1
and slightly in excess of 108 PFU/ml at the end of pas-
age 2. Thus, the cotransfection method of rescue re-
ulted in efficient recovery of NDV. After passage 2, the
ell culture passaged virus was plaque purified to elim-
nate vaccinia virus and then individual plaques were
sed to inject 9-day-old embryonated eggs. No plaques
ere visualized nor HA titer quantified in the case of
egative controls, further confirming the specificity of
ecovery of NDV from cDNA. The recovered virus was
esignated rNDV/BC, to distinguish it from the parental
ild-type NDV (pNDV/BC). The allantoic fluid containing
he recovered and amplified NDV was analyzed in a
emagglutination inhibition (HI) test by using NDV anti-
erum and NDV HN-specific MAbs 15C4, AVS, and
0D11. The reactivities with antiserum and monoclonal
ntibodies were similar for both the parental and recom-
inant strains of NDV (Table 2).
mmunological staining of cells infected with
ecovered virus
FIG. 1. Full-length NDV cDNA assembled in pBR322/dr from subgeno
to scale). The blocked arrows indicate the primers used in RT-PCR. Th
the first nucleotide of the primer, represented 59 to 39. Plasmid pBR322/d
oligonucleotide linker between the EcoRI and PstI sites, an 84-nuc
ranscription termination signal. Transcription by the T7 RNA polymeras
residues at the 59 terminus.When DF1 cells were infected with the rNDV/BC, ex-
ensive fusion was observed and the cytopathic effect
r
rCPE) was as robust as that of pNDV/BC. Infected allan-
oic fluid or cell culture supernatant was used to produce
laques on DF1 cells. The plaques were then visualized
y immunological staining, using either an NDV poly-
lonal sera or MAb against the NDV HN protein (Fig. 2).
pecific staining of plaques indicated NDV replication
nd expression of NDV proteins. The plaque size was
dentical to that of the parental virus. No positive signals
ere observed in the case of negative controls.
dentification of genetic markers in the recovered
irus
Two genetic markers (MluI and AgeI) were introduced
n the full-length NDV cDNA clone to unambiguously
dentify the recovered virus. To identify these markers in
he rNDV/BC, HA-positive allantoic fluid was subjected to
NA extraction and RT-PCR. Control experiments con-
irmed that the PCR products were dependent on reverse
ranscription. The RT-PCR product that was amplified to
emonstrate the MluI site marker was subjected to re-
triction enzyme digestion with enzymes MluI. The sec-
nd product that served to demonstrate the AgeI site
arker was digested with the enzyme AgeI. Upon aga-
A fragments (I to VIII) that were generated by high-fidelity RT-PCR (not
ers shown above the primers represent the position in the genome of
modified form of plasmid pBR322, designed to include a 72-nucleotide
HDV antigenome ribozyme sequence and a T7 RNA polymerase
e plasmid pNDVf1 results in the NDV antigenomic RNA with 3 nonviralmic cDN
e numb
r is the
leotideose gel electrophoresis of the digested products, the
estriction enzyme patterns revealed the existence of
l HDV ri
p
r
t
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171RECOVERY OF VIRULENT STRAIN OF NDV FROM CLONED cDNAboth genetic markers in rNDV/BC (Fig. 3, lanes 2 and 4).
Nucleotide sequence analysis of cloned PCR products
confirmed the sequences spanning the restriction site
markers. This confirmed the rNDV/BC to be the recom-
binant derived from cloned full-length cDNA.
Growth characteristics of the recombinant virus
Replication in a multistep growth cycle for rNDV/BC
and pNDV/BC was evaluated following infection of the
virus in triplicate in DF1 cells at a multiplicity of infection
(m.o.i.) of 0.005. The samples were collected at 6-h in-
tervals for a period of 36 h. The viruses in the samples
were later quantitated by plaque assays. Both the kinet-
ics and the magnitude of replication of the two viruses
were very similar, which indicated that the growth of
rNDV/BC was not adversely affected by the genomic
changes in the full-length NDV cDNA (Fig. 4).
T
Oligonucleotide Primers Used during
cDNA
fragments P
I 1 59ACTGGGGCGCGCCTAATACGACTCACT
2 59AGACCCGCGGCTGGGTTGACTTCCCTG
II 1 59AGACCCGCGGAAACAGCCAGG39
2 59GCAGGGGCCCATCTTGCACCTAGAA39
III 1 59ACAGGGGCCCCAGACCTTCTACCAA39
2 59ATCGACGCGTAGTTTTTTCTAAACTCTC
IV 1 59ATCGACGCGTTGTAGATGACCAAAG39
2 59GCACACCGGTAGCTGTTTTGCCTTGTA
V 1 59GCACACCGGTAAATAGTACGGGTAGGA
2 59TTCAGCTTAGCGAAGATCCGTCCATTAA
VI 1 59TTCAGCTAAGCTGACAAAGAAGTTAAG
2 59AAGCCTTAAGAACAATGTTTGGGCTTG
VII 1 59AAGCCTTAAGAAACATACGCAAAGAGT
2 59TCAGAGGCCTTCTTACTCTCAGATAATA
VIII 2 59TCAGAGGCCTTCTTACTCTCAGATAATA
59ATGCCGGACCGcgaggaggtggagatgccat
Note. The cDNA fragments correspond to the fragments in Fig. 1. T7
are underlined, and restriction sites are marked in bold type. The partia
of the primer sequence is shown for sense (1) and antisense (2).
TABLE 2
HI Titers of Antisera and MAbs
Strain
Titera
NDV
serum
MAb
AVS
MAb
15C4
Mab
10D11
NDV/BC 4096 8 4096 256
NDV/BC 8192 32 8192 512
a Expressed as the reciprocal of the highest dilution of serum or MAb
hat caused inhibition of hemagglutination. Results for control serum
ere negative.Pathogenicity of the recombinant virus
One of the pathogenicity tests to determine the viru-
lence of the original Beaudette C strain and of the newly
generated recombinant Beaudette C strain was con-
ducted by performing the mean death time (MDT) in
eggs. To determine MDTs of the original and the recom-
binant Beaudette C strains, different dilutions of
rNDV/BC and pNDV/BC were injected into the allantoic
cavity of 9-day-old embryonated, specific-pathogen-free
(SPF) chicken eggs and the mean death time for the
minimum lethal dose to kill the eggs was recorded. The
MDTs for rNDV/BC (62 h) and pNDV/BC (60 h) were very
similar, indicating pathogenicity of infection in eggs is
identical for both viruses (Table 3).
The test for assessing the virulence of NDVs in birds
was conducted by determining the intracerebral patho-
genicity index (ICPI) in day-old chicks. ICPI is an inter-
nationally accepted procedure for assessment of viru-
lence of NDV isolates. The test is performed by inocu-
lating the birds intracerebrally and scoring for the
appearance of clinical signs and mortality. The observa-
tion and scoring are done every 24 h for a period of 8
days (Alexander, 1989). The ICPI is the mean score per
bird per observation over the 8-day period. The most
virulent NDV strains give indices close to 2.0, while
avirulent viruses give values close to 0.0. In our experi-
ments, the result of ICPI for pNDV/BC was 1.58 and for
rNDV/BC was 1.63 (Table 3). These values are within the
range expected for the wild-type Beaudette C and show
ength cDNA Synthesis and RT-PCR
Order of
cloning
ACCAAACAGAGAATCCGTAAGTTAG39 8
7
6
5
39 2
G39 4
9
3
1
CCACCAAACAAAGATTTGGTGAATAACAAG39
ter sequences are marked in italic type, the virus-specific sequences
bozyme sequence (24-nt) overhang is shown in lowercase. OrientationABLE 1
Full-L
rimers
ATAGG
39
39
TC39
CATG
GT39
GAACT
CAAC3
CCT39
GAG39
GAG39
gccgAC
promothat the recombinant NDV is similar in virulence and
pathogenesis to the natural pathogen.
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173RECOVERY OF VIRULENT STRAIN OF NDV FROM CLONED cDNARecovery and characterization of recombinant NDV
encoding CAT protein
After we developed the system to recover infectious
recombinant NDV from cloned cDNA, we decided to use
reverse genetics to explore the potential of NDV to ex-
press a foreign gene. The introduction of the CAT open
reading frame (ORF) flanked by NDV gene start and gene
end sequence motifs in the location between the HN and
L ORF of pNDVf1 resulted in the production of a cDNA
encoding a longer antigenome of 15,882 nucleotides.
The potential for this antigenomic RNA to be rescued into
NDV particles and the ability of virus to sustain the
production of additional mRNA and CAT protein stably
were assessed. The strategy of construction of this
cDNA is shown in Fig. 5. The scheme for recovering
FIG. 3. Identification of genetic markers in the genome of rNDV/BC
(lanes 1 to 5) and confirmation of the location and size of CAT gene in
the genome of the recombinant rNDV/BC/CAT (lanes 6 to 8). RT-PCR
was performed from the genomic RNA purified either from viruses
amplified in embryonated chicken eggs (for demonstration of genetic
markers) or from viruses in the cell culture supernatants (for confirma-
tion of CAT gene location). The RT-PCR products corresponding to
pNDV/BC and rNDV/BC (lanes 1 to 4) were both digested by MluI (lanes
1 and 2) or AgeI (lanes 3 and 4). The PCR/digested products were run
n a 1% agarose gel in the presence of ethidium bromide. Lanes 5 and
refer to PCR without the RT step.
FIG. 2. Plaques produced by pNDV/BC (A), rNDV/BC/ (B), rNDV/BC/C
0.9% methylcellulose were incubated for a period of 4 days. After this period,
against the NDV HN protein.infectious NDV was similar to that described previously,
except that the transfectant supernatant was passaged
to fresh cells and a total of eight serial passages were
completed at intervals of 4 days, with each passage
obtaining an m.o.i. of approximately 0.01. The recovery of
NDV encoding CAT (rNDV/BC/CAT) was first assessed
by the appearance of CPE on DF1 cells. The onset of
CPE was delayed compared to onset in rNDV/BC, thus
indicating a slower growth cycle. The plaque size of the
CAT-containing recombinant was smaller, with an aver-
age diameter of 50–60% that of rNDV/BC virus (Fig. 2).
The presence of the CAT gene in the genome of
recombinant was verified by RT-PCR amplification, with
the oligonucleotide primers located in the coding region
of HN [NDV (1)-sense primer corresponding to positions
7743 to 7765] and L [NDV (2)-sense primer correspond-
ing to positions 9350 to 9372) genes. The result showed
a single fragment on analysis of rNDV/BC and rNDV/BC/
CAT RNAs (Fig. 3). The size of the PCR product corre-
sponding to rNDV/BC/CAT RNA conformed well to the
predicted size of 2325 nucleotides, which would include
the size of the CAT transcription cassette (Fig. 3, lane 7).
The presence of a single fragment on RT-PCR ruled out
any population with partial loss of the CAT gene.
Since the rNDV/BC/CAT virus displayed delayed CPE,
we investigated whether this virus exhibited slower
growth than that of rNDV/BC. To do this, cells in triplicate
were infected with either rNDV/BC or rNDV/BC/CAT at an
m.o.i. of 0.005, and samples were taken at 6-h intervals
and quantitated by plaque assays. Both the growth ki-
FIG. 4. Multistep growth curve for pNDV/BC, rNDV/BC, and rNDV/
BC/CAT and viruses in DF1 cells. Cell monolayers in 25-cm2 flasks
were infected with 0.005 PFU/cell with three replicate flasks per virus.
Samples were taken every 6 h for 36 h. The virus in the supernatant
was titrated by plaque assay. The log titer is derived from the average
of the virus titer.
, and rNDV/BC/(2)CAT (D) on DF1 cells. Infected cells overlayed withAT (C)
the plaques were visualized by immunological staining using a MAb
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174 KRISHNAMURTHY, HUANG, AND SAMALnetics and the final titer of rNDV/BC/CAT relative to that
of rNDV/BC were lower (Fig. 4). The maximum titer
achieved was more than 100-fold lower than that of
rNDV/BC.
CAT enzyme expression and stability
To verify the expression of CAT protein from rNDV/BC/
CAT, cell lysates from the transfectant and all of the eight
serial passages were analyzed for CAT activity. Surpris-
ingly, the transfectant lysate showed a high level of CAT
expression, while the lysate from passage 1 showed no
activity. This result can be explained by the fact that, after
transfection, most of the CAT expression is probably
mediated after the promiscuous transcription of the CAT
gene either by one of the vaccinia virus polymerases or
after the production of positive-sense RNA from the
transfected plasmid by the T7 RNA polymerase. No CAT
activity was detectable at passage level 1, probably be-
cause of the low titer of the virus. Efficient CAT expres-
sion was detectable in cells of passage level 2 and
onward, indicating higher titer of the virus (Fig. 6 depicts
CAT expression of P2 and P8 only). These results also
show that the CAT gene was stable for at least eight
passages. In addition to identifying the CAT enzyme
activity by CAT assay, immunoprecipitation of cell lysates
FIG. 5. Construction of pNDVf1/CAT by insertion of the CAT gene cD
sequences represent the oligonucleotide primer used for amplifying th
contained the gene start (GS) signal, noncoding (NC) sequence, and g
as a multiple of six. The RNA encoded by pNDVf1/CAT included the thwas conducted to characterize CAT protein synthesis.
DF1 cells were labeled with [35S]methionine and cell
vysates were analyzed by polyacrylamide gel electro-
horesis, both before and after immunoprecipitation.
recipitation with anti-CAT antibodies revealed the pres-
nce of a single species of CAT polypeptide in rNDV/BC/
AT-infected cells, but not in rNDV/BC-infected cells
Fig. 7).
nalysis of mRNAs by Northern blot hybridization
A separate CAT transcription cassette in the genome
f NDV should suggest the synthesis of an additional
olyadenylated mRNA. The presence of this mRNA and
he levels of expression of HN and L mRNA, the genes of
to HN and L intergenic region of the plasmid pNDVf1. The nucleotide
ORF. The resulting PCR product with the AgeI overhang on either end
d (GE) signal. The nucleotide length of the construct was maintained
terminal nonviral G residues contributed by the T7 promoter.
TABLE 3
MDT in Eggs and ICPI in Day-Old Chicks
Strain MDTa ICPIb
pNDV/BC 60 h 1.58
rNDV/BC 62 h 1.63
rNDV/BC/CAT 75 h 1.50
rNDV/BC/(2)CAT 63 h NDc
a Lentogenic strains, MDT . 90 h; mesogenic strains, MDT 5 60–90
; velogenic strains, MDT , 60 h.
b Lentogenic strains, ICPI , 0.7; mesogenic strains, ICPI 5 0.7–1.6;NA in
e CATelogenic strains, ICPI . 1.6.
c ND, not determined.
175RECOVERY OF VIRULENT STRAIN OF NDV FROM CLONED cDNAwhich flank the CAT gene, were tested by Northern blot
hybridization. The hybridization was performed on RNA
from cells infected with rNDV/BC and rNDV/BC/CAT,
each at passage level 6.
Hybridization of the mRNAs extracted from rNDV/BC/
CAT-infected cells with the negative-sense CAT-specific
riboprobe detected a single major band of the predicted
size of CAT mRNA (Fig. 8, lane 2). There were no detect-
able shorter forms of CAT mRNA. Negative-sense ribo-
probes specific to HN and L genes were also used for
hybridization of replicate blots. The levels of HN and L
mRNAs were significantly less for rNDV/BC/CAT than for
rNDV/BC (Fig. 8). Comparison between the relative
amounts of various mRNAs was not possible because of
the different probe used for each. However, densitometry
scanning was used to determine the percentage of ra-
dioactivity present in each mRNA band of rNDV/BC and
rNDV/BC/CAT. The values of mRNAs of rNDV/BC/CAT
were 24% (HN) and 13% (L), considering a value of 100%
for each of the mRNAs of rNDV/BC. This result implicated
a lower amount of the viral mRNA accumulation in the
cells infected with the slower-growing CAT-containing
recombinant virus.
Pathogenicity of rNDV/BC/CAT
The pathogenicity of CAT-expressing recombinant
NDV in eggs was assessed by injecting different dilu-
tions of virus into the allantoic cavity of 9-day-old embry-
onated SPF chicken eggs. The MDT was calculated as
the time that is required for a minimum lethal dose to kill
FIG. 6. CAT expression by rNDV/BC and rNDV/BC/CAT during pas-
sage 2 and passage 8. Cell lysates were analyzed for acetylation of
[14C]chloramphenicol by thin-layer chromatography.the eggs. The MDT for rNDV/BC/CAT was higher (75 h)
than that for rNDV/BC (62 h) (Table 3). This implicates
attenuation of virus pathogenicity for the CAT gene-con-
taining recombinant NDV.
Similarly, assessment of pathogenicity in day-old
chicks revealed a lower ICPI value for rNDV/BC/CAT (an
FIG. 7. Immunoprecipitation of CAT protein from cells infected with
rNDV/BC/CAT virus labeled with 35S-methionine. Proteins were immu-
noprecipitated with anti-CAT antibodies from lysates of cells infected
with rNDV/BC (lane 3) and rNDV/BC/CAT (lane 4). Aliquots of total
protein from lysates of rNDV/BC (lane 1) and rNDV/BC/CAT (lane 2)
were analyzed in parallel. Numbers on the right are molecular weight
in kilodaltons. The detection of CAT protein required longer exposure
(36 h) of the autoradiograph than that of the total protein (15 h).
FIG. 8. Northern blot hybridization of intracellular CAT, HN, and L
mRNAs encoded by rNDV/BC and rNDV/BC/CAT. Poly A (1) mRNAs
were isolated from total intracellular RNA by oligo (dT) chromatography
and were electrophoresed on formaldehyde–agarose gels. The gels
were transferred to nitrocellulose membrane and probed with the
negative-sense riboprobe.
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176 KRISHNAMURTHY, HUANG, AND SAMALICPI value of 1.5) than that for rNDV/BC (ICPI of 1.63).
Thus, introduction of an additional gene into the NDV
genome might represent a method of attenuation of the
virus to birds.
Growth and biological properties of CAT gene-deleted
version of recombinant
To confirm that attenuation or decrease in growth of
CAT gene-containing recombinant was due to the pres-
ence of an extra gene and not due to any extraneous
mutation in the genome, we decided to recover and
characterize the virus obtained by transfecting a CAT
gene-deleted version of pNDVf1/CAT. To do this, pNDV/
CAT was digested with restriction enzyme AgeI, to re-
move the CAT gene, and was religated back to obtain the
plasmid containing the full-length NDV genome, but de-
void of the CAT gene. Transfection of this plasmid led to
the recovery of a recombinant virus (designated rNDV/
BC(2)CAT), identical in growth characteristics and bio-
logical properties to the virus rNDV/BC. There was a
reversion back to MDT (Table 3), plaque size (Fig. 2), and
growth characteristics (data not shown) of rNDV/BC, im-
plicating that growth impairment and attenuation of
rNDV/BC/CAT resulted entirely from the inclusion of an
additional gene.
DISCUSSION
In this report, we describe the recovery of an infec-
tious mesogenic strain of NDV (strain Beaudette C) en-
tirely from cDNA. Although La Sota, a lentogenic strain of
NDV was recently recovered from cDNA (Oberdorfer et
al., 1999; Peeters et al., 1999), this is the first report of the
recovery of a mesogenic strain of NDV. Mesogenic
strains are suitable candidates for the study of genetic
manipulation that could result in more attenuated or
more virulent viruses. In this study, a vaccinia-based
system was used. This system, in which the recombinant
vaccinia virus provides the T7 RNA polymerase to syn-
thesize the antigenomic RNA from the full-length plasmid
and the proteins NP, P, and L from the cotransfected
plasmids, has also been used to recover several other
nonsegmented negative-stranded RNA viruses. The
problems associated with the presence of vaccinia virus
in the recovery system are minimized, largely because
the fast growth of NDV eliminates the need for early
separation of vaccinia virus. HEp-2 cells were chosen for
transfection because this human tissue-derived cell line
is relatively more resistant to MVA-T7-induced cytopa-
thology, is readily transfectable, and supports NDV
growth. After transfection, we tested two different ap-
proaches to recovering the virus. In terms of virus titer
generated, either passage of the virus from the transfec-
tion harvest in the egg or a chicken embryo-derived cell
line proved highly efficient. NDV was recovered three of
three times on numerous occasions by these methods.
i
wTherefore, both these methods of recovery can be uti-
lized to recover NDV particles entirely from cDNA.
Several members of paramyxoviruses replicate effi-
ciently only if their genome nucleotide length is a multi-
ple of 6 (Calain and Roux, 1993; Durbin et al., 1997b;
urphy and Parks, 1997; Sidhu et al., 1995). The natural
enome length of NDV is a multiple of 6 (de Leeuw and
eeters, 1999; Krishnamurthy and Samal, 1998; Phillips et
l., 1998), but certain minigenome lengths other than the
ultiple of 6 have been found to replicate with measur-
ble efficiency (our unpublished data). We, however,
ave maintained the full-length cDNA as a multiple of 6
o maximize the efficiency of recovery. Sequence analy-
is of the full-length NDV cDNA showed five nucleotide
hanges compared to the published sequence of NDV
eaudette C strain. These sequence changes resulted in
ne amino acid substitution in the HN protein and two
mino acid substitutions in the L protein. We wanted to
etermine whether these nucleotide changes were the
esult of misincorporation during RT-PCR or were present
n our parental NDV strain Beaudette C. Viral genomic
NAs isolated from three different stocks of NDV strain
eaudette C were subjected to RT-PCR with primers that
pecifically amplified the regions containing the changed
ucleotides. The PCR fragments were cloned and sev-
ral clones were sequenced. All clones derived from
hree different virus stocks showed the changes in the
ucleotides compared to the published sequence. These
esults indicate that the substitution of five nucleotides
ound in our full-length NDV cDNA were present in our
arental virus. Therefore, it is apparent that the wild-type
DV strain Beaudette C has accrued nonlethal point
utations during serial passages over the years. Addi-
ionally, introduction of two genetic markers resulted in a
otal of five nucleotide substitutions in the F/HN and
N/L intergenic regions of the full-length cDNA. These
hanges did not adversely affect the recovery of the
irus. As expected, the three additional G residues ad-
acent to the T7 promoter did not inhibit the rescue of
DV. Removal of extra G residues from the end of the
enome was previously documented in VSV (Pattnaik et
l., 1992) and NDV (Peeters et al., 1999).
The successful recovery of NDV from cDNA clones will
ermit genetic manipulation of the entire genome of
DV. Recombinant NDVs can be generated to study
tructure–function relationships of individual viral genes
nd to analyze promoter elements and other noncoding
equences. One of the outcomes of these studies will
ead to unraveling the molecular basis of NDV pathogen-
sis. NDV is an ideal model to study the pathogenesis of
aramyxoviruses not only because NDV strains vary
rom mild to highly virulent but also because the patho-
enesis experiments can be carried out directly in the
atural host, chickens. Determination of the function ofndividual NDV proteins, especially F, HN, and V proteins,
ill be helpful to elucidate the molecular basis of NDV
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ing better vaccines for Newcastle and other paramyxo-
virus diseases.
One other application of reverse genetics would be to
use the recombinant viruses to express additional pro-
teins. In the last few years, several research groups used
negative-strand RNA viruses to express foreign proteins
(Baron et al., 1999; Bukreyev et al., 1996; Hasan et al.,
1997; He et al., 1997; Luytjes et al., 1989; Mebatsion et al.,
1996; Sakai et al., 1999; Schnell et al., 1996; Spielhofer et
l., 1998). The results of these studies showed that the
xpression levels of foreign proteins are quite high and
oreign genes are very stable after many passages in
itro and in vivo. In the present study, the reverse genet-
cs system was used to generate an NDV recombinant
ontaining a foreign gene. A transcription cassette of
acterial CAT gene was inserted into the HN/L intergenic
egion of the full-length cDNA. The CAT gene was in-
erted in this region by analogy to schemes used for VSV
nd SV5 (He et al., 1997; Schnell et al., 1996). We chose
the CAT gene for this study because of its small size and
the existence of an excellent assay system for the en-
zyme. Flanked by NDV gene start and gene end signals,
the CAT gene should be subjected to transcription and
expression strategy similar to that of other NDV genes.
We deduced that insertion of a new cistron downstream
of the HN gene would have minimal effects on viral
replication, perhaps reducing the L gene expression
slightly in consequence of the polarity of transcription.
The total genome length was maintained as a multiple of
six nucleotides for efficient replication of the recombi-
nant virus. CAT expression was observed in cell culture
infected with the virus for each of the eight passages.
Thus, the CAT gene was maintained stably in the NDV
recombinant without any detectable loss of any part of
the gene. The growth of the virus was delayed, however,
and a maximum titer 100-fold lower than that of the
wild-type recombinant was noted. A decrease in virus
production resulting from the presence of an additional
gene was also reported in other nonsegmented nega-
tive-strand viruses (Bukreyev et al., 1996; Hasan et al.,
1997; Sakai et al., 1999). The presence of the additional
gene also resulted in an increase in MDT.
We also assessed the virulence of the virus to birds by
determining its ICPI. This procedure of determining vir-
ulence is highly sensitive and reproducible and is the
only method currently accepted by the Office of Interna-
tional Epizootics for pathotyping NDV isolates. A lower
ICPI for the CAT-expressing recombinant (a value of 1.5)
than for the wild type recombinant (a value of 1.63)
proved that the inclusion of the CAT gene in the NDV
genome results in attenuation. Recently, we recovered
NDV recombinant-expressing green fluorescent protein
(GFP), with the GFP gene inserted between the F and HN
genes of the full-length cDNA clone (unpublished data).
Our initial results show that this recombinant also exhib-its reduced growth in cell culture and a decreased viru-
lence to eggs. This finding indicates that any gene intro-
duced as an additional transcriptional unit in the NDV
genome is likely to be associated with the reduced
growth and attenuation of the recombinant virus. An
implication of all these results is that NDV can be engi-
neered to express foreign protein stably and can be
manipulated in the future for use as a vaccine vector.
Several factors need to be addressed regarding ex-
pression levels, size of the foreign gene, and attenuation.
It is necessary to explore the functional attributes of the
intergenic and noncoding regions of NDV. This knowl-
edge should lead to finer insertion strategies for the
foreign gene, thereby achieving a balance between the
expression level of the foreign or viral genes and the
attenuation level of the virus. As shown for other viruses,
the expression level of the foreign gene in NDV should
be high when placed near the 39 end of the genome,
ecause of the polarity of transcription (Sakai et al., 1999;
Wertz et al., 1998). Additionally, the upper size limit of the
foreign gene that can be inserted into the NDV genome
needs to be investigated, to achieve expression of mul-
tiple/larger genes. Although the upper size limit of the
insertion that negative-stand RNA viruses can accommo-
date is not known, results from several studies indicated
that these viruses can tolerate large size inserts. In
Sendai virus, a 3.2-kb foreign gene (Sakai et al., 1999)
was inserted and expressed efficiently. Multiple genes,
adding up to 4.2 kb of RNA, were introduced into recom-
binant VSVs (Roberts and Rose, 1998).
An important application of this work will be in the
development of NDV as a vaccine vector for the expres-
sion of protective antigens of other avian pathogens.
Several characteristics of NDV already suggest its suit-
ability as a vaccine vector for avian pathogens: (1) Live
NDV vaccines are widely used in poultry with proven
track records of efficacy and safety. (2) NDV naturally
infects the respiratory tract, leading to the induction of
both mucosal and systemic immunity. Therefore, NDV
would be a suitable vector for antigens of agents infect-
ing respiratory tract and other organs. (3) NDV does not
show measurable rates of recombination. Therefore,
NDV strains cannot create new variants. (4) NDV repli-
cates independently of nuclear functions and thus can-
not integrate into cellular DNA that can result in cellular
transformation or viral persistence. The last three fea-
tures confer advantages over the live recombinant vac-
cine vectors derived from pox and herpes viruses. Addi-
tionally, pox and herpes virus vectors express the foreign
proteins in combination with a large repertoire of pro-
teins encoded by their large-size genomes (Moss and
Flexner, 1987). In contrast, the foreign protein in NDV is
expressed with only seven other proteins. For the gen-
eration of specific immune responses in vaccine appli-
cations, it will be advantageous to have only a limited
number of proteins expressed. All these factors favorably
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178 KRISHNAMURTHY, HUANG, AND SAMALaugur the use of NDV as a vaccine vector. Techniques of
reverse genetics should augment this use significantly.
In summary, we have described the successful recov-
ery of a mesogenic strain of NDV from positive-sense
transcripts of a cDNA clone. Availability of a functional
cDNA clone should be useful for basic studies of NDV
molecular biology and pathogenesis. In addition, we
have demonstrated that the NDV genome can accept
and maintain an additional gene. An important applica-
tion of this work will be in the development of NDV as an
attenuated vaccine vector for the delivery of heterolo-
gous viral proteins.
MATERIALS AND METHODS
Cells and viruses
HEp-2 and DF1 cells were grown and maintained in
Dulbecco’s modified Eagle’s medium (D-MEM) contain-
ing 10% fetal calf serum. NDV strain Beaudette C was
obtained from The National Veterinary Services Labora-
tory (Ames, IA). The virus was grown in 9-day-old embry-
onated SPF chicken eggs by injecting the virus in the
allantoic cavity. Two days later, the allantoic fluid was
harvested and clarified, and the virus was purified as
described previously (Kingsbury, 1966).
cDNA synthesis and construction of NDV full-length
plasmid
Viral RNA was extracted from the purified virus by the
use of TRIzol (Life Technologies, Gaithersburg, MD) ac-
cording to manufacturer’s protocol. A total of eight cDNA
fragments, spanning the entire NDV genome, were gen-
erated by RT-PCR (Fig. 1). Specifically, each cDNA frag-
ment was primed by a positive-sense oligonucleotide
primer (Table 1), which carried a recognition sequence
for a restriction enzyme that was unique or present two
or more times in the genome. The primer corresponding
to the fragment I had a T7 promoter overhang 39 to the
scI restriction site, and the primer corresponding to
ragment VIII had a 24-nt 39-end sequence overhang of
DV ribozyme sequence. Also, the positive-sense oligo-
ucleotide primer corresponding to fragment IV was
odified at nt positions 6294 and 6295 to create an MluI
site tag (at the F/HN intergenic region), and the negative-
sense oligonucleotide primer corresponding to fragment
V was modified at nt positions 8357, 8358, and 8359 to
create an AgeI site tag (at the HN/L intergenic region).
The first-strand cDNA was synthesized using Thermo-
script RT-PCR kit (Life Technologies) according to the
manufacturer’s protocol. Subsequently, PCR was per-
formed using high-fidelity Pfu DNA polymerase (Strat-
gene, La Jolla, CA) in a reaction containing the primer
sed in the RT reaction and the corresponding negative-
ense oligonucleotide primer (Table 1). The RT-PCR
roduct was then digested with the respective restrictionenzymes and ligated to the plasmid pBR322/dr (Fig. 1).
The fragments were ligated sequentially in the order
shown in Table 1. Plasmid pBR322/dr was constructed by
modification of plasmid pBR322. The modification in-
cluded a backbone of 72-nt linker between the EcoRI and
PstI sites, and an HDV 84-nt antigenome ribozyme se-
quence and T7 RNA polymerase transcription termina-
tion signal downstream of the polynucleotide linker. After
ligation into the plasmid, each fragment was sequenced
completely by the dideoxy chain termination method
(Sanger et al., 1977). The resulting NDV full-length ex-
ression plasmid was termed pNDVf1.
onstruction of expression plasmids
cDNA fragments bearing the open reading frame
ORF) of NP, P, and L genes were generated by RT-PCR.
he NP gene was cloned in the plasmid pGEM 7Z (pNP)
etween EcoRI and BamHI sites. The cloned gene was
equenced completely by the dideoxy chain termination
ethod. The P and L genes were cloned in an expres-
ion plasmid, which has an encephalomyocarditis virus
EMCV) internal ribosome entry site (IRES) downstream
f the T7 RNA polymerase promoter and makes use of
he translation start codon contained in NcoI site of IRES.
he cloned genes were sequenced to entirety by the
ideoxy chain termination method (Sanger et al., 1977).
Construction of full-length plasmid containing
CAT gene
The restriction enzyme site of AgeI at position 8358 of
pNDVf1 was utilized to insert the CAT gene between the
ORF of HN and the L gene (Fig. 5). The ORF encoding the
CAT protein was engineered to contain NDV gene start
and gene end sequences. Specifically, the positive-
sense oligonucleotide primer used to amplify the CAT
gene by PCR was modified to contain the gene start
sequence and a noncoding region of 4 nt downstream of
the AgeI site and upstream of the CAT-specific se-
quence. The negative-sense oligonucleotide primer con-
taining the AgeI site overhang included a noncoding
region of 5 nt, and the gene end sequence for the CAT
gene apart from the CAT-specific sequence. PCR was
performed by the use of high-fidelity Pfu DNA polymer-
ase (Stratagene). The PCR-amplified fragment was in-
serted at the AgeI site of pNDVf1 and the resulting
plasmid was designated pNDVf1/CAT. The integrity of the
entire foreign sequence was confirmed by sequencing
using the dideoxy chain termination method (Sanger et
al., 1977). This plasmid thus resulted in a 40-nt intergenic
region between HN and the CAT gene and a 14-nt inter-
genic sequence between CAT and the L gene. The in-
sertion of 696 nucleotides of foreign sequence (a nucle-
otide multiple of six) resulted in the plasmid encoding an
antigenome of 15,882 nucleotides.
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179RECOVERY OF VIRULENT STRAIN OF NDV FROM CLONED cDNATransfection and recovery of recombinant NDV
The HEp-2 cells were chosen for transfection experi-
ments because these cells are permissive for NDV,
transfect efficiently, and are resistant to CPE of vaccinia
virus strain MVA. Specifically, cells grown to 80% conflu-
ency in six-well plates were washed twice with Opti-
MEM just before transfection. The cells were then trans-
fected with 5 mg pNDV, 2.5 mg pNP, 1.5 mg pP, and 0.5 mg
of pL in a volume of 0.2 ml of Opti-MEM/well. The trans-
fection was carried out with Lipofectamine Plus (Life
Technologies), according to the manufacturer’s instruc-
tions. Along with the transfection mixture, 1 focus-form-
ing unit per cell of recombinant vaccinia virus (MVA/T7)
expressing T7 RNA polymerase was added in a volume
of 0.8 ml Opti-MEM/well. Twelve hours later, the medium
was replaced with 3 ml Opti-MEM containing 2% fetal
bovine serum (FBS) and 40 mg of cytosine arabinoside/
l. Four days after transfection, the medium was har-
ested, the cell debris was pelleted by low-speed cen-
rifugation, and the supernatant was used for infecting a
resh batch of HEp-2 cells in 25-cm2 flasks. The virus in
the supernatant was allowed to adsorb for 6 h and was
then replaced with 5 ml of D-MEM containing 2% FBS
and 40 mg/ml cytosine arabinoside. After one additional
passage in DF1 cells (at a passage interval of 4 days) the
supernatant was plaque purified. Plaque purification was
performed on DF1 cells and individual plaques were
used to inject 9-day-old embryonated chicken eggs
through the allantoic route. Alternatively, 100 ml superna-
ant from transfection was directly used to inject 9-day-
ld embryonated chicken eggs. Two days later, the eggs
ere chilled for a period of 12 h, after which the allantoic
luid was harvested. The virus in the allantoic fluid was
mplified by further passage in eggs.
ntibody staining of plaques
The plaques produced by the recovered virus were
tained by NDV-specific antibodies. The assay was per-
ormed by using an overlay consisting of Opti-MEM me-
ium supplemented with 2% fetal bovine serum and 0.9%
ethyl cellulose (reagents from MCB, Norwood, OH).
fter incubation for 4 days at 37°C, the overlay was
emoved and the monolayer was fixed with 80% metha-
ol. The plaques were then incubated with either NDV
hicken polyclonal antisera or monoclonal antibody spe-
ific to NDV HN. This was followed by incubation with
ither goat anti-chicken IgG or sheep anti-mouse IgG,
oth tagged with horseradish peroxidase. Plaques were
hen stained by reaction with substrate.
T-PCR and demonstration of genetic markers
RT-PCR was performed on the RNA extracted from re-
ombinant virus. Specifically, recombinant virus grown in
he allantoic cavity of five 9-day-old embryonated eggs was
s
earvested, clarified, and purified as described previously
Kingsbury, 1966). RNA was extracted from one-third of the
urified virus by TRIzol (Life Technologies) and then sub-
ected to first-strand cDNA synthesis using the Thermo-
cript RT-PCR kit (Life Technologies). One of the reactions,
hich served to demonstrate the MluI marker (at position
293 of the genome), was performed using the synthetic
ligonucleotide primer that bound to the F gene sequence:
9-GATGTGTAAACCCCCCGGGTAT-39 (positions 5742 to
763 in the full-length cDNA). The negative-sense oligonu-
leotide primer for PCR was derived from the HN gene
equence: 59-CTCTTCATAGTCCCTATACATTC-39 (positions
721 to 7743 in the full-length cDNA). The second reaction
as designed to demonstrate the AgeI marker (at position
358 of the genome) and was primed with an oligonucleo-
ide primer that hybridized to the HN gene sequence: 59-
AATGGCCTTCACTCGGCCAGGT-39 (positions 7743 to
765 in the full-length cDNA). The negative-sense oligonu-
leotide primer for PCR was derived from the L gene se-
uence: 59-GCTATATCATTGGGGAGGA-39 (positions 9354
o 9372 in the full-length cDNA). The RT-PCR product was
hen subjected to restriction enzyme digestion: the first
roduct with enzyme MluI, the second product with enzyme
geI. The restriction patterns were then demonstrated by
garose gel electrophoresis. A parallel experiment was
onducted on the parental strain of Beaudette C as control.
RT-PCR was also performed to demonstrate the location
f the CAT gene insert in the recombinant NDV expressing
he CAT protein. The virus in the supernatant of passage 8
as utilized for extraction of viral RNA. Specifically, PEG
000 was added to the supernatant at a final concentration
f 10% and allowed to mix at 4°C for 3 h. The mixture was
hen centrifuged at 4000 rpm in a Beckmann GPKR centri-
uge (GH3.7 rotor) for 15 min. The supernatant was dis-
arded and the pellet was resuspended in a small amount
f D-MEM. RNA was extracted from the suspension by
RIzol (Life Technologies) and subjected to first-strand
DNA synthesis using the Thermoscript RT-PCR kit (Life
echnologies). The reaction was performed using the oli-
onucleotide primer, 59-CAATGGCCTTCACTCGGCCAGGT-
9, which is positive-sense and represents positions 7743 to
765 in the full-length cDNA. PCR was then performed by
sing the above-mentioned oligonucleotide and a negative-
ense oligonucleotide primer 59-GCTATATCATTGGG-
AGGA-39, representing positions 9354 to 9372 in the full-
ength cDNA. These two primers flank the CAT gene and
art of the HN and L genes. The recombinant NDV without
he CAT gene insertion in the genome was analyzed in
arallel.
AT assays and passage of recombinant NDV
ncoding CAT
CAT expression was assayed for a total of eight pas-
ages. At the end of transfection and first passage the
ntire media supernatant was used for passing the virus
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180 KRISHNAMURTHY, HUANG, AND SAMALto fresh DF1 cells in 25-cm2 flasks. But at the end of
every other passage, one-thirteeth of the media super-
natant was used for passing to fresh DF1 cells. A total of
eight serial passages were performed at a passage
interval of 4 days. The cell pellets were utilized for the
CAT assay and RNA isolation. For the CAT assay, the cell
pellets were lysed by three freeze/thaw cycles and one-
tenth of the lysed pellet was analyzed by thin-layer chro-
matography for the ability to acetylate [14C]chlorampheni-
col (Gorman et al., 1982).
Isolation of poly (A)1 RNA and Northern blot
hybridization
The virus from passage level 6 was quantitated by
plaque assay and 10 m.o.i. of the virus was used to infect
DF1 cells in a 25-cm2 flask. After 24 h, the cell pellet was
ollected by centrifugation, then resuspended in a few
rops of D-MEM; total RNA was extracted with TRIzol
eagent (Life Technologies) as recommended by the
anufacturer. The total RNA was utilized to extract poly
A)1 RNA by using the poly(A) tract mRNA isolation sys-
em IV kit (Promega, Madison, WI). mRNA samples (each
epresenting one-tenth of one T-25 cell) were analyzed
y electrophoresis on 1.5% agarose gels containing 0.44
formaldehyde, run at 110 V for 2 h. The gel was then
ransferred to a nitrocellulose membrane (pore size, 0.2
mm) using the Turbo-Blot apparatus (Schleicher &
Schuell, Keene, NH) with a transfer buffer containing 3 M
NaCl and 8 mM NaOH. The RNA was crosslinked to the
membrane by the UV crosslinker (Stratagene). The mem-
brane was then subjected to prehybridization for 8 h at
65°C in 63 SSC containing 0.1% SDS, 53 Denhardt’s
solution, and 0.5 mg/ml of sheared salmon sperm DNA.
Hybridization was performed overnight in the same so-
lution after addition of the appropriate 2 3 106 dpm of
32P]CTP-labeled negative-sense probe. The probe was
ynthesized by in vitro transcription of linearized plasmid
GEM7Z containing either the complete gene of CAT
cloned between the XbaI and BamHI sites of the plas-
id) or the partial gene of HN or L (cloned between the
baI and HindIII sites of the plasmid), all under the
ontrol of T7 RNA polymerase promoter. Washing of the
embrane after hybridization was done in 103 SSC–1%
DS at 65°C for 1 h. A second washing was done in 0.1%
SC and 0.1% SDS at 65°C for 1 h. Blots were then
xposed overnight to X-ray film. The density of the hy-
ridized bands was estimated with a densitometer (Mo-
ecular Dynamics, Sunnyvale, CA).
mmunoprecipitation and polyacrylamide gel
lectrophoresis
DF1 cell monolayers in a 25-cm2 flask were infected
ith rNDV/BC or rNDV/BC/CAT at 10 PFU/cell. At 6 h
ostinfection, the cells were starved in a methionine-free
edium (Life Technologies) for 30 min. At the end of thetarvation period, 50 mCi of [35S]methionine (1000 Ci/
mmol; Amersham, Arlington Heights, IL) per ml was
added to the flask. Twelve hours later the labeled cells
were washed three times with cold phosphate buffer
saline and lysed in 0.3 ml of cold radioimmunoprecipita-
tion assay (RIPA) buffer [20 mM Tris (pH 7.5), 150 mM
NaCl, 5 mM EDTA (pH 8.0), 0.5% sodium deoxycholate,
0.1% sodium dodecyl sulfate (SDS), 1.0% Triton X-100].
The lysates were clarified by centrifugation at 4°C. The
lysate was then incubated at room temperature with 5 ml
f purified CAT-specific polyclonal rabbit antibody (5
rime3 3 Prime, Boulder, CO) for a period of 4 h. At the
nd of this period, 50 ml of Staphylococcus aureus pro-
tein A (Life Technologies) was added and the samples
were shaken at 4°C for 1 h. The immune complexes
were collected by centrifugation at 16,000 g for 30 s. The
complex was washed twice with solution I (0.1% Triton
X-100, 0.02% SDS, 150 mM NaCl, 50 mM Tris–HCl, pH 7.4,
and 5 mM EDTA) and twice with solution II (150 mM
NaCl, 50 mM Tris–HCl, pH 7.4, and 25 mM EDTA). The
pellet was resuspended in 30 ml of sample buffer and
then boiled for 3 min prior to loading on a 15% polyacryl-
amide gel. Following electrophoresis, the gels were fixed
for 1 h in 30% methanol and 10% acetic acid, dried, and
exposed to X-ray film.
Pathogenicity test in eggs
MDT in eggs was determined for each virus, to assess
the pathogenicity in eggs. A series of 10-fold dilutions of
infected allantoic fluid were made in sterile PBS, and 0.1
ml of each dilution was inoculated into the allantoic
cavity of each of the five 9-day-old embryonated SPF
chicken eggs. The eggs were stored at 37°C and exam-
ined four times daily for 7 days. The time that each
embryo was first observed dead was recorded. The
highest dilution at which all eggs died was considered
the minimum lethal dose. The MDT was recorded as the
mean time in hours for the minimum lethal dose to kill the
embryos. The MDT has been used to classify NDV
strains into velogenic (taking under 60 h to kill), meso-
genic (taking between 60 and 90 h to kill), and lentogenic
(taking more than 90 h to kill).
Pathogenicity test in birds
ICPI was used to determine the virulence of wild-type
and recombinant NDVs in day-old chicks. For each ICPI
test, 15 one-day-old chicks (10 birds for test and 5 birds
for control) were used. These birds were from SPF flocks
that were known to be free of antibodies to NDV. The
inoculum consisted of fresh infective allantoic fluid with
a HA titer of .24 (1/16) for the test birds and allantoic
fluid from normal uninfected 12-day-old embryonated
chicken eggs for control birds, both inocula being diluted
1/10 in sterile PBS. The inoculation was done using a
27-gauge needle, attached to a 1-ml stepper syringe
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181RECOVERY OF VIRULENT STRAIN OF NDV FROM CLONED cDNAdispenser that was set to dispense 0.05 ml of inoculum
per inoculation. The birds were inoculated intracere-
brally by inserting the needle up to the hub into the left or
right rear quadrant of the cranium. The birds were ob-
served and scored every 24 h for a period of 8 days. The
scoring and determination of ICPI were done according
to the method described by Alexander (1989).
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